Results 151 to 160 of about 3,819 (202)

Acute management of spontaneous intracerebral hemorrhage (ICH) in the emergency department. [PDF]

Int J Emerg Med
Puissant M, Ganti L.
europepmc   +1 more source

Thrombolysis for Ischemic Stroke Despite Recent Ingestion of Direct Oral Anticoagulants - A Growing Dilemma Also in India. [PDF]

Ann Indian Acad Neurol
Meinel TR, Paramasivan NK, Menon BK, Fischer U, Seiffge DJ.   +4 more
europepmc   +1 more source

Andexanet Alfa in Urgent Cardiac Surgery: A Case Report of Edoxaban Reversal for Acute Hemopericardium. [PDF]

Am J Case Rep
Al Mawed M, Warkentin H, Brockmeier JP, Schramm R, Gummert J, von Dossow V, Gielen S.   +6 more
europepmc   +1 more source

Hemorrhagic Events Associated With Direct Oral Anticoagulants: Frequency and Management. [PDF]

Cureus
Ztati M, Zaanouny O, Nasim A, El Hattaoui M.   +3 more
europepmc   +1 more source

Cardiac Tamponade and Duodenal Hemorrhage Caused by Inappropriate Use of Dabigatran in a Patient With End-Stage Renal Failure: A Case Report. [PDF]

Cureus
Hayashida M, Suzuki M, Nakata Y, Kakita H, Eizawa H.   +4 more
europepmc   +1 more source

Anticoagulants beyond coagulation: a narrative review of cardiovascular effects. [PDF]

Cardiovasc Res
Aarts A, Ten Cate H, Ten Cate-Hoek AJ.
europepmc   +1 more source

Intravenous Thrombolysis in Patients on Direct Oral Anticoagulants: Analysis of the Get With The Guidelines Stroke Registry. [PDF]

J Am Heart Assoc
Yaghi S, Shu L, Mistry EA, Adeoye O, Schwamm L, Messe S, Elkind MSV, Ghannam M, de Havenon A, Furie K, Xian Y, Streib C, Wangqin R, Henninger N, Saver JL, Smith EE.   +15 more
europepmc   +1 more source

Specific Reversal Agents for Direct Oral Anticoagulants in Acute Stroke. [PDF]

Clin Appl Thromb Hemost
Frol S, Pretnar Oblak J, Šabovič M, van Zwam WH, Ntaios G, Lövblad KO, Gruber A, Kermer P.   +7 more
europepmc   +1 more source

Reversal of direct oral anticoagulants: guidance from the SSC of the ISTH: comment. [PDF]

J Thromb Haemost
Moore HB, Barrett CD.
europepmc   +1 more source

ANMCO/SIMEU consensus document on the use of reversal agents for antithrombotic therapies in patients with ongoing bleeding or at high risk of haemorrhagic events. [PDF]

Eur Heart J Suppl
De Luca L, Pugliese FR, Susi B, Navazio A, Corda M, Fabbri A, Scicchitano P, Voza A, Vanni S, Bilato C, Geraci G, Gabrielli D, Grimaldi M, Colivicchi F, De Iaco F, Oliva F.   +15 more
europepmc   +1 more source